Key result
Angptl2 deficiency in a mouse model decreased abdominal aortic aneurysm development, reducing aneurysmal size and expression of proinflammatory cytokines and matrix metalloproteinase-9.
Why the study?
Does Angptl2 deficiency prevent abdominal aortic aneurysm development in a CaCl2-induced mouse model?
Population
Patients with abdominal aortic aneurysm and a CaCl-induced AAA mouse model
Comparison
Angptl2 deficiency and Angptl2-deficient bone… vs Wild-type mice
Design
Preclinical
Authors
Loading...
Angptl2 inhibition merits preclinical AAA study; leaves open human translation from this mouse model.
Does Angptl2 deficiency prevent abdominal aortic aneurysm development in a CaCl2-induced mouse model?
Macrophage-derived Angptl2 promotes abdominal aortic aneurysm development via inflammation and extracellular matrix degradation, highlighting a potential novel therapeutic target.
Tazume et al. (2012) studied Abdominal aortic aneurysm. Angptl2 deficiency vs. Wild-type was evaluated on AAA development. Angptl2 deficiency in a mouse model decreased abdominal aortic aneurysm development, reducing aneurysmal size and expression of proinflammatory cytokines and matrix metalloproteinase-9.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: